Nutron Pharmaceuticals Private Limited

Nutron Pharmaceuticals Private Limited - chemicals and materials in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
CIN U24230MH1990PTC058515 Incorporated 12 October 1990 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Private Limited Company chemicals and materials MSME · Medium
Data last updated
Revenue · FY 2025
₹51.48 Cr
▲ 1% YoY
Net profit · FY 2025
₹5.42 Cr
Net margin 10.5%
EBITDA · FY 2025
₹6.89 Cr
EBITDA margin 13.4%
Authorised capital
₹25 Lakh
Registered with MCA
Paid-up capital
₹4.83 Lakh
Issued & subscribed
Open charges
₹15 Cr
Satisfied ₹26.94 Cr
Company age
36 yrs
Est. 1990
Directors on board
7
As per MCA filings

About Nutron Pharmaceuticals Private Limited

Data last updated:

Nutron Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the chemical distribution and retail segment of the chemicals and materials sector. It was incorporated on 12 October 1990 and has been in existence for over 36 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH1990PTC058515. Its GSTIN is 27AAACN9128K1Z5 (Maharashtra).

The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹4.83 Lakh. It is led by directors including Ritesh Ramesh Shah and Praful Ramesh Shah.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 401 Earth Sampann Bldg 198/200 Khetwadi Main Road 4th Floor, Mumbai, Maharashtra, India – 400004.

As per the financials filed for FY 2025, the company reported a revenue of ₹51.48 Cr, a growth of 1% compared to the previous year. For the same year it recorded a net profit of ₹5.42 Cr (net margin 10.5%) and EBITDA of ₹6.89 Cr (EBITDA margin 13.4%). Revenue has declined at a compounded annual rate (CAGR) of 20% over three years and 2% over five years.

As per MCA filings, the company has open charges of ₹15 Cr and satisfied charges of ₹26.94 Cr on record. Court records list 6 cases involving the company, including 5 filed by the company and 1 filed against it; 1 case is pending. The company has 1 deal on record (1 secondary share transfer); the latest was in March 2011. Its 6 peer companies in the Chemicals industry (Chemical Retail and Distribution, Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading) are compared by revenue, 4 larger and 2 smaller; the largest is Vatika Distributors Private Limited with revenue of ₹51.65 Cr. The company has 2 MSME Form 1 returns on record for the period ending Mar 2023, listing 42 overdue payments to 12 micro and small suppliers.

Nutron Pharmaceuticals Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-19-0195660). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website nutron.lookchem.com.

Company details

CIN U24230MH1990PTC058515
Registration Number 058515
Incorporation Date 12 October 1990
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-MH-19-0195660
Key People
Ritesh Ramesh Shah Director Praful Ramesh Shah Director Popatlal Hanjarimal Shah Director

Recognitions & Rankings of Nutron Pharmaceuticals

MSME (Udyam registered) Ministry of MSME
Category
Medium (2024-25)
Udyam number
UDYAM-MH-19-0195660

Contact details

Nutron Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra. Its website is nutron.lookchem.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Website
    nutron.lookchem.com
  • Registered Address
    401 Earth Sampann Bldg 198/200 Khetwadi Main Road 4th Floor, Mumbai, Maharashtra, India – 400004
  • Industry
    Chemicals and Materials, Chemical Distribution & Retail

To see the full contact details of Nutron Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Nutron Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Nutron Pharmaceuticals is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Nutron Pharmaceuticals Private Limited, buy the company report.

Financials of Nutron Pharmaceuticals Private Limited

FY 2025 filings available

Nutron Pharmaceuticals Private Limited reported revenue of ₹51.48 Cr (up 1% YoY) for FY 2025.

Revenue · FY 2025
₹51.48 Cr ▲ 1%
Net profit · FY 2025
₹5.42 Cr margin 10.5%
EBITDA · FY 2025
₹6.89 Cr margin 13.4%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 1%
3 years · compounded
▼ 20%
5 years · compounded
▼ 2%
EBITDA CAGR growth
1 year
▲ 32%
3 years · compounded
▼ 27%
5 years · compounded
▲ 4%

Revenue rose 1% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 2%. EBITDA rose 32% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹6.89 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹5.42 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin13.4%
Net Profit Margin10.5%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Nutron Pharmaceuticals Private Limited, buy the company report.

Board of directors of Nutron Pharmaceuticals Private Limited

Nutron Pharmaceuticals has 7 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Ritesh Ramesh Shah
Also directs: Mehal Enterprise LLP, Terrapolis Buildcon Private Limited, New Dholera Shipping & Trading Co Limited and 1 more
Director18 Oct 201214 Years 0 MonthsCurrent
Praful Ramesh ShahDirector18 Oct 201214 Years 0 MonthsCurrent
Popatlal Hanjarimal ShahDirector12 Oct 199036 Years 0 MonthsCurrent
Jayesh Popatlal Shah
Also directs: Mehal Enterprise LLP, Terrapolis Buildcon Private Limited
Director15 Mar 199927 Years 7 MonthsCurrent
Ramesh Hanjarimal Shah
Also directs: Mehal Enterprise LLP
Director12 Oct 199036 Years 0 MonthsCurrent
Manish Bhuralal Shah
Also directs: Mehal Enterprise LLP, Terrapolis Buildcon Private Limited
Director03 Apr 199531 Years 6 MonthsCurrent
Showing 6 of 7 current directors. View all directors

Peer comparison

Nutron Pharmaceuticals Private Limited is compared with the 6 companies closest to it by revenue in the Chemicals industry (Chemical Retail and Distribution, Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Vatika Distributors Private Limited₹51.65 Cr (FY 2025)8.0%Kolkata, West Bengal, India
Venus Chemcorp Private Limited₹51.56 Cr (FY 2025)15.0%Mumbai, Maharashtra, India
Metrix Healthcare Private Limited₹51.51 Cr (FY 2017)31.0%Ahmedabad, Gujarat, India
Toyo Ink Arets India Private Limited₹51.49 Cr (FY 2024)11.0%New Delhi, Delhi, India
Nutron Pharmaceuticals Private Limitedthis company₹51.48 Cr (FY 2025)₹5.42 Cr10.5%1.0%Mumbai, Maharashtra, India
KGN Pharmaceuticals Private Limited₹51.45 Cr (FY 2025)22.0%Mumbai, Maharashtra, India
Sanchay Vanijya Rasayan Private Limited₹51.44 Cr (FY 2024)-6.0%Delhi, India

To see the full peer comparison of Nutron Pharmaceuticals Private Limited, buy the company report.

Auditor

Nutron Pharmaceuticals Private Limited is audited by V. C. SHAH & CO. for the financial year 2023.

Auditor firmFinancial yearFirm registration number
V. C. SHAH & CO.FY 2023109818W

Shareholding

The shareholding of Nutron Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Nutron Pharmaceuticals Private Limited, buy the company report.

Charges & borrowings

Open charges
₹15 Cr
Satisfied charges
₹26.94 Cr
Breakdown by lending institutions
Others₹15.00 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
30 Jan 2021100426510Others₹15 CrOpen
15 Feb 200810087088Citi Bank N.A.₹22.5 CrSatisfied
05 Mar 200710056464Citibank N.A.₹2.5 CrSatisfied
17 Sep 200390232255The Sangli Bank Limited₹1.5 CrSatisfied
28 Jul 199890232092Bank of Madura Ltf₹9.33 LakhSatisfied

To see the full charge records of Nutron Pharmaceuticals Private Limited, buy the company report.

Total charge records: 7 View all charges

Deals & funding

Nutron Pharmaceuticals Private Limited has 1 deal on record (1 secondary share transfer); the latest was in March 2011.

Total deals
1
Secondary share transfer
1

Deals on record (1 of 1)

WhenDealAmountParties
Mar 2011Secondary share transferUndisclosedBuyer: an individual
Seller: an individual

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

Nutron Pharmaceuticals Private Limited has 2 MSME Form 1 returns on record for the period ending Mar 2023, listing 42 overdue payments to 12 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 12)

SupplierAmount dueDue sinceReported on
Relic Chemicals
R R Innovative P Ltd
Gurudev Dye-Chem Private Limited
Sanjay Chemicals (India) Private Limited
Sparchem

To see the full MSME payment records of Nutron Pharmaceuticals Private Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

GST

Nutron Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
27AAACN9128K1Z5MaharashtraActive01 Jul 2017

To see the full GST registrations and return filing status of Nutron Pharmaceuticals Private Limited, buy the company report.

Recent activity

Nutron Pharmaceuticals Private Limited has 9 board changes on record since 1990: 7 appointments and 2 cessations. The latest: Praful Ramesh Shah ceased to be Additional Director on 24 Sep 2013.

AGM
Nutron Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Nutron Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Charges
A charge registered on 15 Feb 2008 via Charge ID 10087088 with Citi Bank N.A. was fully satisfied on 18 Jul 2022.
Charges
A charge registered on 05 Mar 2007 via Charge ID 10056464 with Citibank N.A. was fully satisfied on 18 Jul 2022.
Charges
A charge with Others of Rs. 1,500.00 Lakh registered on 30 Jan 2021 with Charge ID 100426510 was modified on 25 Nov 2021.
Charges
A charge with Others amounted to Rs. 1,500.00 Lakh with Charge ID 100426510 was registered on 30 Jan 2021.
Charges
A charge registered on 17 Sep 2003 via Charge ID 90232255 with The Sangli Bank Limited was fully satisfied on 20 Jan 2020.
Charges
A charge registered on 28 Jul 1998 via Charge ID 90232092 with Bank Of Madura Ltf was fully satisfied on 20 Jan 2020.
Charges
A charge registered on 07 Jan 1997 via Charge ID 90232002 with Bank Of Madura Ltd was fully satisfied on 20 Jan 2020.
Charges
A charge registered on 28 Dec 1995 via Charge ID 90230869 with Bank Of Madura Ltd was fully satisfied on 20 Jan 2020.
Charges
A charge with Citi Bank N.A. of Rs. 2,250.00 Lakh registered on 15 Feb 2008 with Charge ID 10087088 was modified on 01 Nov 2019.
Ceased
Praful Ramesh Shah ceased to be Additional Director.

16 earlier events are in the company report.

Frequently asked questions

Nutron Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in chemical distribution and retail, within the chemicals and materials industry. It was incorporated on 12 October 1990 (36+ years old) and is registered under CIN U24230MH1990PTC058515.

Nutron Pharmaceuticals has 7 current directors:

The latest financial statements of Nutron Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Nutron Pharmaceuticals is 27AAACN9128K1Z5, registered in Maharashtra.

The CIN (Corporate Identification Number) of Nutron Pharmaceuticals is U24230MH1990PTC058515. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Nutron Pharmaceuticals has 6 court cases on record: 5 filed by the company and 1 filed against it. 1 is pending. Most are in the district courts.

Nutron Pharmaceuticals was incorporated on 12 October 1990, making it 36+ years old. It is registered with the Registrar of Companies, Mumbai.

Nutron Pharmaceuticals has 1 deal on record (1 secondary share transfer); the latest was in March 2011.

The peers of Nutron Pharmaceuticals by revenue are Vatika Distributors Private Limited, Venus Chemcorp Private Limited, Metrix Healthcare Private Limited, Toyo Ink Arets India Private Limited, KGN Pharmaceuticals Private Limited and 1 more, all in the Chemicals industry (Chemical Retail and Distribution, Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).

Praful Ramesh Shah ceased to be Additional Director on 24 Sep 2013. Ritesh Ramesh Shah ceased to be Additional Director on 24 Sep 2013. Praful Ramesh Shah was appointed as Director on 18 Oct 2012. Nutron Pharmaceuticals has 9 board changes on record in total.

Yes, Nutron Pharmaceuticals is registered as a medium enterprise under Udyam registration (number: UDYAM-MH-19-0195660).

Nutron Pharmaceuticals has 2 MSME Form 1 returns on record for the period ending Mar 2023, listing 42 overdue payments to 12 micro and small suppliers. The latest return was filed on 31 Aug 2023.